InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Mack Gene. Director active across 1 company, notably Gain Therapeutics, Inc.. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €13k. Activity tracked since 9 August 2024. The latest transaction was disclosed on 9 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration